外周液体栓塞剂市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00039169
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 233
Buy Now

Peripheral Liquid Embolic Agents Market Forecast (2024-2031)

Buy Now

外周液体 栓塞剂市场规模预计将从 2023 年的 4042 万美元增至 2031 年的 8141 万美元。预计 2023-2031 年期间市场复合年增长率为 9.1%。人们对温度诱导相变系统和 pH 触发栓塞剂的关注度和发展度不断提高,可能会为外周液体栓塞市场带来新的趋势

外周液体栓塞剂市场分析

液体栓塞剂主要用于微创手术,如栓塞术,用于治疗动脉瘤、动静脉畸形、肿瘤和其他疾病。这些药物提供了一种比传统手术方法侵入性更小的替代方法,使医生能够更好地控制和精确关闭血管,同时最大限度地减少患者的创伤和恢复时间。技术创新有望提高产品性能,并促进其在各种下游应用中的广泛应用。此外,由于患者和医疗保健专业人员越来越意识到液体栓塞剂在治疗外周血管疾病方面的好处,外周液体栓塞剂市场正在增长,因为患者和医疗保健专业人员越来越多地采用和接受它。

外周液体栓塞剂市场概况

液体栓塞剂用于治疗外周血管疾病,如精索静脉曲张和外周动脉栓塞。患者和医疗保健专业人员对微创手术的偏好日益增加,推动了这些药物的市场发展。随着全球医疗支出不断增加以及新兴市场医疗基础设施不断改善,液体栓塞剂等最新医疗技术的引入,推动了外周液体栓塞剂市场的扩张。此外,许多国家对使用液体栓塞剂的微创手术实行优惠的报销政策,这也促进了这些手术的接受度并推动了市场扩张。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

外周液体栓塞剂市场:

外周液体栓塞剂市场

  • 复合年增长率(2023 - 2031)
    9.1%
  • 2023 年市场规模
    4042 万美元
  • 市场规模 2031
    8141 万美元

市场动态

增长动力
  • 耳部感染患病率不断上升推动市场增长
未来的趋势
  • 企业促进市场增长的战略举措
机会
  • 人们对耳朵健康的认识不断提高,有利于市场增长

关键人物;主力;重要一员

  • 奥林巴斯美国公司,
  • 美敦力,
  • 峰会医疗,
  • 格雷斯医疗
  • Preceptis 医疗
  • Atos 医疗,
  • Medasil 外科有限公司
  • Adept Medical Limited,
  • 史密斯和侄子公司,
  • Integra 生命科学

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 管敷贴器/插入器
  • 鼓膜置管
材料
  • 硅酮
  • 氟塑料
  • 不锈钢
应用
  • 急性中耳炎
  • 复发性渗出性中耳炎
最终用户
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

外周液体栓塞剂市场驱动因素和机遇

外周血管疾病发病率上升

外周血管病 (PVD) 包括外周动脉病 (PAD) 和静脉病。PVD 患病率的不断上升可归因于人口老龄化的加剧,这增加了其各种诊断和治疗方法的可见性。根据美国国家医学图书馆发表的文章“与收入相关的外周动脉疾病治疗”,全世界有超过 2 亿人患有 PAD,西欧和北美 50 岁及以上人群中约有 10% 患有该疾病。PVD 的患病率范围为 55 岁以上患者的 3%、65 岁以上患者的 11% 和 75 岁以上患者的 20%。根据美国国家医学图书馆发表的一项题为《中国外周动脉疾病流行病学模式和危险因素的长期趋势》的研究,2000年至2020年间,中国外周动脉疾病的患病人数增加了40%。2020年,中国约有4100万成年人患有外周动脉疾病。2020年,中国的流行病学研究还发现,中国35岁以上一般人群外周动脉疾病的患病率为6%,60岁以上老年人外周动脉疾病的患病率为15%。据估计,全国有超过3000万外周动脉疾病患者。

PVD 患病率的上升归因于与糖尿病、吸烟、肥胖和年龄相关的风险因素的增加。由于不健康的生活方式改变和药物不足以治疗 PVD ​​症状,使用外周支架的微创手术通常是标准治疗方法。脑血管/颈动脉疾病、外周动脉疾病和腹主动脉瘤是初级保健医生报告的最常见的外周血管病。所有这些都需要积极的医疗治疗以防止潜在的严重并发症,并需要血管外科医生进行评估。液体栓塞剂通常使用 X 射线成像(即血管造影)引导的导管注射并引入血管畸形部位。输注液体栓塞剂后,它会通过离子或热过程,根据不同的机制(包括沉淀、聚合和交联)原位变为固体植入物。液体栓塞剂不依赖患者的凝血系统来完全闭塞,即使对于患有严重凝血病的患者也可能有效。如果导管无法到达出血部位,液体栓塞剂可在导管尖端远端提供栓塞。欧洲心脏病学会 (ESC)、欧洲血管外科学会 (ESVS)、美国心脏协会 (AHA) 和美国心脏病学会 (ACC) 等所有主要地区都建议采取长期治疗策略、改善疗效和制定法规以降低心血管死亡率。因此,PVD 的日益流行推动了外周液体栓塞剂市场的增长。

市场参与者不断增加的战略举措

市场参与者始终致力于保持其在市场上的领导地位,通过不断致力于战略举措、推出新产品和改进现有产品来扩大外周液体栓塞剂的使用范围。

  • 2023 年 11 月,Fluidx Medical Technology 宣布开发其超外周栓塞平台,用于止血、肿瘤治疗和其他近端栓塞应用。新闻稿称,该超平台旨在使基于导管的治疗栓塞程序更安全、更好、更快捷。
  • 2023 年 10 月,Sirtex Medical 宣布推出 LAVA - 液体栓塞系统,这是一种获批用于治疗外周血管出血的液体栓塞剂。LAVA 提供容量和粘度选项,可优化治疗受控靶血管闭塞患者的灵活性。该产品的 2 mL 和 6 mL 选项针对外周血管进行了优化,其粘度选项可实现无法通过其他栓子进入的小血管的远端栓塞。
  • 2023年5月,远大医药集团有限公司收购了Blackswan Vascular Inc. 87.5%的股份,该公司开发用于外周血管应用的液体栓塞。该公司继续扩大其在肿瘤干预领域的业务。

因此,基于进步和战略举措的新产品发布可能会为外周液体栓塞剂市场提供新的机遇在未来的几年里。

外周液体栓塞剂市场报告细分分析

有助于得出外周液体栓塞剂市场分析的关键部分是类型和应用。

  • 根据类型,外周液体栓塞剂市场分为聚合液体栓塞剂和沉淀液体栓塞剂。2023 年,沉淀液体栓塞剂细分市场占有较大的市场份额,预计在 2023-2031 年期间将实现更高的复合年增长率。
  • 根据应用,市场细分为内漏类型 II、畸形、出血和创伤、静脉曲张、肿瘤和内脏动脉瘤。2023 年,内漏类型 II 占据了最大的市场份额。然而,出血和创伤部分预计在 2023 年至 2031 年期间的复合年增长率最高。

外周液体栓塞剂市场份额(按地区)分析

外周液体栓塞剂市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美占据外周液体栓塞剂市场的最大份额。血管疾病发病率的不断上升、市场参与者不断增加的战略举措、政府的支持性计划以及创新液体栓塞产品的开发推动了区域市场的增长。2023 年,加拿大占据了北美外周液体栓塞剂市场的最大份额。由于先进的医疗保健基础设施的可用性和目标疾病发病率的不断上升,预计市场将会增长。然而,预计亚太地区在 2023-2031 年期间的复合年增长率最高。亚太市场的增长受到多种因素的推动,例如外周动脉疾病(PAD) 患病率的上升、对微创手术的需求不断增加、医院和门诊手术中心数量的不断增加、市场参与者将重点放在发展中国家以寻找增长机会以及发展亚太地区的医疗保健基础设施。在该地区,中国在 2023 年占据了最大的市场份额,因为中国的市场参与者正在开展战略活动以扩大其在市场上的影响力。 2021年5月,远大医药健康控股有限公司收购沈明医疗科技有限公司,公司获得用于肝癌治疗的创新热敏栓塞剂的全部权利,进一步丰富了肿瘤介入治疗产品管线。

外周液体栓塞剂市场报告范围

报告属性细节
2023 年的市场规模4042万美元
2031 年市场规模8141万美元
全球复合年增长率(2023 - 2031)9.1%
历史数据2021-2022
预测期2024-2031
涵盖的领域按产品
  • 管敷贴器/插入器
  • 鼓膜置管
按材质
  • 硅酮
  • 氟塑料
  • 不锈钢
按应用
  • 急性中耳炎
  • 复发性渗出性中耳炎
按最终用户
  • 医院
  • 门诊手术中心
  • 专科诊所
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 奥林巴斯美国公司,
  • 美敦力,
  • 峰会医疗,
  • 格雷斯医疗
  • Preceptis 医疗
  • Atos 医疗,
  • Medasil 外科有限公司
  • Adept Medical Limited,
  • 史密斯和侄子公司,
  • Integra 生命科学
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

外周液体栓塞剂市场新闻和最新发展

通过收集一手和二手研究后的定性和定量数据来评估外周液体栓塞剂市场,其中包括重要的公司出版物、协会数据和数据库。下面列出了外周液体栓塞剂市场的一些发展情况:

  • CERENOVUS Inc. 推出了 TRUFILL n-BCA 液体栓塞系统手术套件。CERENOVUS 出血性中风产品组合的最新成员提供了 TRUFILL n-BCA 液体栓塞系统,这是一种新的手术套件,包括两种配置以及在一个无菌套件中准备和输送 n-BCA 液体栓塞系统所需的配件,从而简化了手术准备。(来源:强生公司,新闻稿,2024 年 3 月)
  • Sirtex Medical(“Sirtex”)推出了首款用于治疗外周血管出血的产品。LAVA 提供容量和粘度选项,可优化治疗受控制靶血管闭塞影响患者的灵活性。该产品能够最大限度地提高靶血管内的填充密度,这一点非常重要,因为它可以最大限度地降低未来复发或恢复血管通畅的可能性。(来源:Sirtex Medical,新闻稿,2023 年 10 月)
  • Balt 在法国开设了第二家办事处。巴黎办事处将容纳销售、营销、临床事务、财务、IT、法律、人力资源和沟通团队的成员。(来源:Balt,新闻稿,2022 年 6 月)

外周液体栓塞剂市场报告覆盖范围和交付成果

“外周液体栓塞剂市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

  • 外周液体栓塞剂市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 外周液体栓塞剂市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 外周液体栓塞剂市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及外周液体栓塞剂市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors impacting the peripheral liquid embolic agents market?

The rising incidence of peripheral vascular diseases and upsurging demand for minimally invasive procedures are among the factors driving the market.

Which are the leading players operating in the peripheral liquid embolic agents market?

Medtronic, Gem Srl, MicroVention Inc, Johnson and Johnson, and Balt are among the leading players operating in the market.

What is the future trend of the peripheral liquid embolic agents market?

The growing focus and developments in temperature-induced phase change systems and pH-triggered embolic agents are likely to bring new trends in the market.

What is the expected CAGR of the peripheral liquid embolic agents market?

The market is expected to register a CAGR of 9.1% during 2023–2031.

The List of Companies - Peripheral Liquid Embolic Agents Market

  1. Medtronic
  2. B Braun SE
  3. Guerbet SA
  4. Sirtex Medical Ltd
  5. Balt
  6. MicroVention Inc
  7. Johnson & Johnson
  8. GEM srl

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports